Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
2025 Standout
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Works of Bertrand Anz being referenced
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial
2022
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bertrand Anz | 457 | 168 | 97 | 380 | 20 | 523 | |
| Владимир Стругов | 450 | 123 | 61 | 381 | 12 | 469 | |
| Andrzej Pluta | 362 | 179 | 90 | 281 | 23 | 497 | |
| Maurice Navarro | 350 | 90 | 66 | 316 | 13 | 492 | |
| Ulrike Söling | 433 | 119 | 76 | 372 | 16 | 506 | |
| Manit Munshi | 516 | 175 | 69 | 452 | 40 | 603 | |
| Manuela A. Bergmann | 543 | 98 | 54 | 490 | 11 | 573 | |
| Marie‐Sarah Dilhuydy | 365 | 133 | 88 | 322 | 29 | 590 | |
| K Merkle | 476 | 146 | 177 | 435 | 23 | 649 | |
| Michael Gulrajani | 529 | 202 | 109 | 399 | 18 | 647 | |
| Yuh Shan Lee | 372 | 93 | 113 | 344 | 17 | 510 |
All Works
Loading papers...